tradingkey.logo

Sharps Technology Inc

STSS
1.650USD
+0.225+15.79%
Close 02/06, 16:00ETQuotes delayed by 15 min
45.58MMarket Cap
LossP/E TTM

Sharps Technology Inc

1.650
+0.225+15.79%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Sharps Technology Inc

Currency: USD Updated: 2026-02-06

Key Insights

Sharps Technology Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 151 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 22.00.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sharps Technology Inc's Score

Industry at a Glance

Industry Ranking
151 / 205
Overall Ranking
517 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Sharps Technology Inc Highlights

StrengthsRisks
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 0.00.
Overvalued
The company’s latest PE is -0.00, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 5.29M shares, increasing 40.64% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 521.63K shares of this stock.

Analyst Rating

Based on 0 analysts
--
Current Rating
22.000
Target Price
+877.78%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Sharps Technology Inc is 5.59, ranking 193 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low.

Score

Industry at a Glance

Previous score
5.59
Change
0

Financials

6.71

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.50

Operational Efficiency

2.83

Growth Potential

4.81

Shareholder Returns

7.07

Sharps Technology Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Sharps Technology Inc is 8.43, ranking 21 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.00, which is -173.68% below the recent high of 0.00 and -52376947.37% above the recent low of -995.16.

Score

Industry at a Glance

Previous score
8.43
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 151/205
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for Sharps Technology Inc. The Healthcare Equipment & Supplies industry's average is 7.77. The average price target is 22.00, with a high of 22.00 and a low of 22.00.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Sharps Technology Inc is 1.04, ranking 205 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 2.22 and the support level at 1.25, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
1.04
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(4)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.097
Sell
RSI(14)
38.238
Neutral
STOCH(KDJ)(9,3,3)
17.187
Neutral
ATR(14)
0.203
Low Volatility
CCI(14)
-103.012
Sell
Williams %R
74.033
Sell
TRIX(12,20)
-0.962
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
1.637
Buy
MA10
1.912
Sell
MA20
2.040
Sell
MA50
2.321
Sell
MA100
3.808
Sell
MA200
4.988
Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Sharps Technology Inc is 5.00, ranking 113 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 18.26%, representing a quarter-over-quarter increase of 20095.35%. The largest institutional shareholder is The Vanguard, holding a total of 521.63K shares, representing 1.80% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score
5.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Schonfeld Strategic Advisors LLC
1.54M
--
Pantera Capital Partners LP
1.15M
--
The Vanguard Group, Inc.
Star Investors
17.85K
+45.56%
Voya Investments, LLC
183.34K
--
OMERS Administration Corporation
81.33K
--
Ruemler (Timothy James)
20.22K
+0.28%
Zhang (Yuwen)
14.04K
--
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Sharps Technology Inc is 1.67, ranking 179 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 2.24. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
1.67
Change
0
Beta vs S&P 500 index
2.21
VaR
--
240-Day Maximum Drawdown
+98.92%
240-Day Volatility
+233.52%

Return

Best Daily Return
60 days
+15.79%
120 days
+52.52%
5 years
--
Worst Daily Return
60 days
-27.03%
120 days
-27.03%
5 years
--
Sharpe Ratio
60 days
-2.10
120 days
-0.79
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+98.92%
3 years
+99.98%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.99
3 years
-0.33
5 years
--
Skewness
240 days
+1.31
3 years
+3.25
5 years
--

Volatility

Realised Volatility
240 days
+233.52%
5 years
--
Standardised True Range
240 days
+180.79%
5 years
--
Downside Risk-Adjusted Return
120 days
-156.21%
240 days
-156.21%
Maximum Daily Upside Volatility
60 days
+97.92%
Maximum Daily Downside Volatility
60 days
+100.33%

Liquidity

Average Turnover Rate
60 days
+122121.10%
120 days
+3592745.59%
5 years
--
Turnover Deviation
20 days
-80.67%
60 days
-87.72%
120 days
+261.14%

Peer Comparison

Healthcare Equipment & Supplies
Sharps Technology Inc
Sharps Technology Inc
STSS
3.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
Align Technology Inc
ALGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI